Racial disparity in the utilization of immunotherapy for advanced prostate cancer
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Racial disparity in the utilization of immunotherapy for advanced prostate cancer
Authors
Keywords
-
Journal
JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2023-10-30
DOI
10.1016/j.jnma.2023.09.007
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer Statistics, 2021
- (2021) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Racial differences in patterns of treatment among men diagnosed with de novo advanced prostate cancer: A SEER‐Medicare investigation
- (2019) Jennifer L. Beebe‐Dimmer et al. Cancer Medicine
- Temporal and geographic variation in the systemic treatment of advanced prostate cancer
- (2018) Megan E. V. Caram et al. BMC CANCER
- Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial
- (2018) Christos E. Kyriakopoulos et al. JOURNAL OF CLINICAL ONCOLOGY
- Castration-Resistant Prostate Cancer: AUA Guideline Amendment 2018
- (2018) William T. Lowrance et al. JOURNAL OF UROLOGY
- Differential use of medical versus surgical androgen deprivation therapy for patients with metastatic prostate cancer
- (2018) Hala T. Borno et al. CANCER
- Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial
- (2018) Christopher C Parker et al. LANCET
- Racial Differences in Prostate Cancer Treatment: The Role of Socioeconomic Status
- (2017) Megan Watson et al. ETHNICITY & DISEASE
- Trends in the Incidence of Fatal Prostate Cancer in the United States by Race
- (2017) Scott P. Kelly et al. EUROPEAN UROLOGY
- EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent
- (2017) Nicolas Mottet et al. EUROPEAN UROLOGY
- Advances in the management of castration resistant prostate cancer
- (2016) Chad R Ritch et al. BMJ-British Medical Journal
- Advances in the management of castration resistant prostate cancer
- (2016) Chad R Ritch et al. BMJ-British Medical Journal
- Disparities in Castration-Resistant Prostate Cancer Trials
- (2015) Daniel E. Spratt et al. JOURNAL OF CLINICAL ONCOLOGY
- Racial Disparities in Prostate Cancer–Specific Mortality in Men With Low-Risk Prostate Cancer
- (2014) Brandon A. Mahal et al. Clinical Genitourinary Cancer
- Getting back to equal: The influence of insurance status on racial disparities in the treatment of African American men with high-risk prostate cancer
- (2014) Brandon A. Mahal et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
- (2013) C. Parker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
- (2012) Howard I. Scher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Abiraterone and Increased Survival in Metastatic Prostate Cancer
- (2011) Johann S. de Bono et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
- (2010) Johann Sebastian de Bono et al. LANCET
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interplay of Race, Socioeconomic Status, and Treatment on Survival of Patients With Prostate Cancer
- (2009) Kendra Schwartz et al. UROLOGY
- Racial Differences in Treatment of Early-Stage Prostate Cancer
- (2008) Kathryn E. Richert-Boe et al. UROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started